AUTL
USDAutolus Therapeutics plc American Depositary Share
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$2.370
High
$2.370
Low
$2.210
Volume
0.19M
Company Fundamentals
Market Cap
596.1M
Industry
Biotechnology
Country
United Kingdom
Trading Stats
Avg Volume
2.19M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Needham analyst Gil Blum reiterates Autolus Therapeutics with a Buy and maintains $10 price target.
Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
Median duration of response in FELIX study now 42.6 months after an additional 11 months of follow upMore than half of patients still in remission at 24 months38% of ongoing responders did not receive any subsequent
Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicityOpinion follows FDA approval and
Related Stocks
SGMO
Sangamo Therapeutics Inc.
EDSA
Edesa Biotech Inc. Common Shares
PXDT
Pixie Dust Technologies Inc. American Depositary Shares
PMN
ProMIS Neurosciences Inc. Common Shares (ON)
PTN
Palatin Technologies Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.